CONCOURSE FINANCIAL GROUP SECURITIES, INC. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
CONCOURSE FINANCIAL GROUP SECURITIES, INC. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$0
-100.0%
0
-100.0%
0.00%
Q2 2023$1,342
-24.0%
2000.0%0.00%
Q1 2023$1,766
+15.6%
2000.0%0.00%
Q4 2022$1,5282000.00%
Q3 2022$0
-100.0%
0
-100.0%
0.00%
Q2 2022$2,000
-33.3%
2000.0%0.00%
Q1 2022$3,000
-84.2%
200
-71.1%
0.00%
-100.0%
Q4 2021$19,000
+171.4%
692
+232.7%
0.00%
Q3 2021$7,000
-12.5%
2080.0%0.00%
-100.0%
Q2 2021$8,000
-75.8%
208
-74.3%
0.00%
-50.0%
Q1 2021$33,000
+175.0%
808
+288.5%
0.00%
+100.0%
Q4 2020$12,000
+20.0%
208
+4.0%
0.00%0.0%
Q3 2020$10,0000.0%2000.0%0.00%0.0%
Q2 2020$10,000
+66.7%
2000.0%0.00%0.0%
Q1 2020$6,0000.0%2000.0%0.00%0.0%
Q4 2019$6,0000.0%2000.0%0.00%0.0%
Q3 2019$6,0002000.00%
Q2 2019$000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders